RAM
INBX icon

Readystate Asset Management’s Inhibrx INBX Stock Holding History

Readystate Asset Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-170,158
Closed -$5.73M – 431
2025
Q3 		$5.73M Buy
170,158
+143,324
+534% +$3.53M 0.24% 88
2025
Q2 		$383K Buy
+26,834
New +$347K 0.01% 467

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Readystate Asset Management's INBX Position: Q4 2025 in Review

Readystate Asset Management sold out of Inhibrx (INBX) in Q4 2025, closing a stake of 170,158 shares — an estimated $5.73M sold.

Readystate Asset Management first reported a position in INBX in Q2 2025 and held it in 2 quarters. The position peaked at $5.73M in Q3 2025. 138 funds tracked by Wall St. Rank hold INBX as of Q4 2025.

  • Readystate Asset Management reported no remaining Inhibrx position as of Q4 2025 after selling out during the quarter.
  • Readystate Asset Management sold 170,158 Inhibrx shares in Q4 2025, an estimated $5.73M.
  • Readystate Asset Management first reported a position in Inhibrx in Q2 2025 and held it in 2 quarters.
  • Readystate Asset Management's Inhibrx position peaked at $5.73M in Q3 2025.
  • 138 funds tracked by Wall St. Rank held Inhibrx as of Q4 2025.

Based on Readystate Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.